Refractory Primary Central Nervous System Lymphoma
1 competing product in clinical development for Refractory Primary Central Nervous System Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tirabrutinib + Tirabrutinib + Tirabrutinib | Ono Pharmaceutical | Phase 2 | Active | 39 |